Sort   by:  
 Page size 
Unknown2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
Not available
S-EPMC6561114 | biostudies-literature
Unknown2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
Not available
S-EPMC6561125 | biostudies-literature
Unknown2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Not available
S-EPMC6788287 | biostudies-literature
Unknown2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Not available
S-EPMC6777949 | biostudies-literature
UnknownConstitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome.
Not available
S-EPMC10022554 | biostudies-literature
UnknownAnti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
Not available
S-EPMC8792092 | biostudies-literature
UnknownAssociation of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Not available
S-EPMC5487292 | biostudies-literature
UnknownCytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
Not available
S-EPMC2674642 | biostudies-literature
Sort   by:  
 Page size